We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.
- Authors
Romero, Alejandro; Ramos, Eva; Patiño, Paloma; Oset-Gasque, Maria J.; López-Muñoz, Francisco; Marco-Contelles, José
- Abstract
Stroke is a disease of aging affecting millions of people worldwide, and recombinant tissue-type plasminogen activator (r-tPA) is the only treatment approved. However, r-tPA has a low therapeutic window and secondary effects which limit its beneficial outcome, urging thus the search for new more efficient therapies. Among them, neuroprotection based on melatonin or nitrones, as free radical traps, have arisen as drug candidates due to their strong antioxidant power. In this Perspective article, an update on the specific results of the melatonin and several new nitrones are presented.
- Subjects
MELATONIN; NITRONES; STROKE treatment; AGE factors in disease; PLASMINOGEN activators; TREATMENT effectiveness
- Publication
Frontiers in Aging Neuroscience, 2016, Vol 8, p1
- ISSN
1663-4365
- Publication type
Article
- DOI
10.3389/fnagi.2016.00281